22 employees
Ocumension Therapeutics is a pharmaceutical platform dedicated to identifying, developing, and commercializing ophthalmic therapies.
$18M sweet spot round size
Most of their 2 investments are in rounds between $16M and $20M
2017
Alimera Sciences raised $20M on April 14, 2021
Investors: Ocumension
pSivida raised $16M on January 3, 2021